NATCO PHARMA LTD.
Cah Flow
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|
Profit Before Tax | 8619.00 | 2022.00 | 5796.00 | 5687.00 | 8247.00 |
Adjustment | 1020.00 | 1239.00 | 621.00 | 540.00 | 143.00 |
Changes In working Capital | 627.00 | -2314.00 | -2129.00 | -976.00 | 86.00 |
Cash Flow after changes in Working Capital | 10266.00 | 947.00 | 4288.00 | 5251.00 | 8476.00 |
Cash Flow from Operating Activities | 8491.00 | 465.00 | 2988.00 | 4173.00 | 6688.00 |
Cash Flow from Investing Activities | -4771.00 | -53.00 | -1033.00 | -1670.00 | -6122.00 |
Cash Flow from Financing Activities | -3630.00 | 348.00 | -1857.00 | -2508.00 | -509.00 |
Net Cash Inflow / Outflow | 90.00 | 760.00 | 98.00 | -5.00 | 57.00 |
Opening Cash & Cash Equivalents | 1111.00 | 258.00 | 198.00 | 283.00 | 217.00 |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | NA | NA | NA | NA | NA |
Cash & Cash Equivalent of Subsidiaries under liquidations | NA | NA | NA | NA | NA |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | NA | NA | NA | NA | NA |
Effect of Foreign Exchange Fluctuations | 118.00 | 93.00 | -38.00 | -80.00 | 9.00 |
Closing Cash & Cash Equivalent | 1319.00 | 1111.00 | 258.00 | 198.00 | 283.00 |